Jonas to head Shire's regenerative medicine business

Shire plc (LSE:SHP; NASDAQ:SHPG) named Jeff Jonas president of Shire's regenerative medicine business, which Shire gained through its acquisition of Advanced BioHealing Inc. last year. Jonas replaces Kevin Rakin, who was chairman and CEO of Advanced BioHealing and led the company's integration with Shire. Shire's Arnaud Partiot will replace Jonas as leader of the company's specialty pharmaceuticals R&D team (see BioCentury Extra, May 17, 2011). ...